Sign In
Get Clay Free →

Suggestions

    David Esposito

    President and Chief Executive Officer at ONL Therapeutics

    David Esposito is a distinguished healthcare CEO and combat veteran known for his success in building and expanding various healthcare companies, leading to profitable acquisitions. He served as the CEO of Armune BioScience, which was acquired by Exact Sciences in December 2017, and as the US President of Phadia US/AB, which was acquired by Thermo Fisher Scientific in September 2011. David holds a Bachelor of Science in Civil Engineering from the United States Military Academy at West Point and an MBA in General Management from Syracuse University's Martin J. Whitman School of Management.

    David Esposito
    Add to my network

    Location

    Ann Arbor, Michigan, United States